A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Neogenomics Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 69,460 shares of NEO stock, worth $735,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,460
Holding current value
$735,581
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

BUY
$6.4 - $10.27 $444,544 - $713,354
69,460 New
69,460 $507,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.33B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.